Sanjay Iyer, MD
Neurology · Charlotte, NCNPI 1376561472
Payments from drug & device makers
Across 896 payments — averaging $764.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$204K
- MDD US Operations, LLC$173K
- Eli Lilly$101K
- Teva Pharmaceuticals USA, Inc.$88K
- Acorda Therapeutics, Inc$44K
- Kyowa Kirin, Inc.$38K
- plus $38K from 17 others
Across 1 payment — averaging $9.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$9
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 239 | $204,303 |
| MDD US Operations, LLC | 359 | $172,697 |
| Eli Lilly | 2 | $101,051 |
| Teva Pharmaceuticals USA, Inc. | 104 | $87,804 |
| Acorda Therapeutics, Inc | 40 | $43,510 |
| Kyowa Kirin, Inc. | 32 | $38,044 |
| Adamas Pharmaceuticals, Inc. | 14 | $20,674 |
| Sunovion Pharmaceuticals Inc. | 22 | $8,810 |
| H. Lundbeck A S | 1 | $3,250 |
| AbbVie(2 entities) | 28 | $2,200 |
| Amneal Pharmaceuticals LLC | 11 | $1,591 |
| Merz Pharmaceuticals, LLC | 11 | $332 |
| Acadia Pharmaceuticals Inc | 13 | $266 |
| Pfizer | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| GE HealthCare | 2 | $54 |
| Lundbeck LLC | 2 | $41 |
| Revance Therapeutics, Inc. | 1 | $34 |
| Avanir Pharmaceuticals, Inc. | 2 | $31 |
| Merz North America, Inc. | 1 | $31 |
| Eisai Inc. | 1 | $27 |
| Boston Scientific | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
How this compares
$684,984 in reported general payments places this provider in the 90th percentile of 566 neurology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Charlotte
- Mohammad BolouriCharlotte$16.6M
- T RaoCharlotte$4M
- Donna GravesCharlotte$1.8M
- Jill ConwayCharlotte$1.6M
- Matthew CarraroCharlotte$1.5M
- Urvi DesaiCharlotte$937K
- Ardith CourtneyCharlotte$862K
- Megan DonnellyCharlotte$601K
- Kenneth AshkinCharlotte$525K
- Leo McCluskeyCharlotte$286K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.